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Btk Regulates Macrophage Polarization in Response to
Lipopolysaccharide
Joan Nı́ Gabhann1, Emily Hams2, Siobhán Smith1, Claire Wynne1,3, Jennifer C. Byrne1, Kiva Brennan2,
Shaun Spence6, Adrien Kissenpfennig6, James A. Johnston7, Padraic G Fallon2,4,5, Caroline A. Jefferies1*
1 Molecular and Cellular Therapeutics and RCSI Research Institute, Royal College of Surgeons in Ireland, Dublin, Ireland, 2 Trinity Biomedical Sciences Institute, Trinity
College Dublin, Dublin, Ireland, 3 School of Biological Sciences, Dublin Institute of Technology, Kevin St, Dublin, Ireland, 4 Institute of Molecular Medicine, St. James’s
Hospital, Trinity College Dublin, Dublin, Ireland, 5 National Children’s Research Centre, Our Lady’s Children’s Hospital Crumlin, Dublin, Ireland, 6 Centre for Infection and
Immunity, School of Medicine Dentistry and Biomedical Sciences, Queen’s University, Belfast, United Kingdom, 7 Amgen Inc., Thousand Oaks, California, United States of
America

Abstract
Bacterial Lipopolysaccharide (LPS) is a strong inducer of inflammation and does so by inducing polarization of macrophages
to the classic inflammatory M1 population. Given the role of Btk as a critical signal transducer downstream of TLR4, we
investigated its role in M1/M2 induction. In Btk deficient (Btk2\2) mice we observed markedly reduced recruitment of M1
macrophages following intraperitoneal administration of LPS. Ex vivo analysis demonstrated an impaired ability of Btk2/2
macrophages to polarize into M1 macrophages, instead showing enhanced induction of immunosuppressive M2-associated
markers in response to M1 polarizing stimuli, a finding accompanied by reduced phosphorylation of STAT1 and enhanced
STAT6 phosphorylation. In addition to STAT activation, M1 and M2 polarizing signals modulate the expression of
inflammatory genes via differential activation of transcription factors and regulatory proteins, including NF-kB and SHIP1. In
keeping with a critical role for Btk in macrophage polarization, we observed reduced levels of NF-kB p65 and Akt
phosphorylation, as well as reduced induction of the M1 associated marker iNOS in Btk2/2 macrophages in response to M1
polarizing stimuli. Additionally enhanced expression of SHIP1, a key negative regulator of macrophage polarisation, was
observed in Btk2/2 macrophages in response to M2 polarizing stimuli. Employing classic models of allergic M2
inflammation, treatment of Btk2/2 mice with either Schistosoma mansoni eggs or chitin resulted in increased recruitment of
M2 macrophages and induction of M2-associated genes. This demonstrates an enhanced M2 skew in the absence of Btk,
thus promoting the development of allergic inflammation.
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and activator of transcription (STAT) proteins and the suppressors
of cytokine signalling (SOCS) family (reviewed in [5]). M1associated gene induction, following stimulation of macrophages
with IFN-c, LPS or TNFa, is mediated by the activation of
STAT1, the p65 subunit of Nuclear factor kappa beta (NF-kB),
phosphoinositide 3-kinase (PI3K) and mitogen-activated protein
kinases (MAPK), resulting in enhanced production of inflammatory cytokines, chemokines and iNOS [6–9]. IL-4 and IL-13
mediate M2 macrophage polarisation by inducing phosphorylation of STAT3 and STAT6 followed by nuclear translocation and
M2-associated gene induction [10,11]. In keeping with the
importance of STAT3 and STAT6 in driving M2 macrophage
polarization, several studies have demonstrated that inhibition of
these proteins promotes an M1 phenotype in macrophages [12–
14]. Additionally Peroxisome proliferator-activated receptor gamma (PPAR-c) and Krüppel-like factor 4 (KLF4) have been
identified as factors that work in concert with STAT6 to promote
an M2 phenotype [15,16]. Another critical modulator of
macrophage polarization is the myeloid restricted Src homology2 domain-containing inositol 5-phosphatase, (SHIP1), which is an

Introduction
Macrophages are central players in the development, progression and resolution of inflammation. Similar to the T cell
paradigm of Th1 and Th2 subpopulations, macrophages polarize
in response to diverse microbial and environmental signals into
various sub-populations with distinct effector functions defined as
classic inflammatory M1 and immunosuppressive M2 macrophages. With respect to their role in disease, increased levels of M1
macrophages are associated with autoimmune and inflammatory
diseases such as lupus nephritis [1] and multiple sclerosis [2]. M2
macrophages on the other hand have been shown to play a role in
promoting tumour growth [3], and in the development of allergic
inflammation and airway disease through their ability to induce
differentiation of Th2 cells (reviewed in [4]).
In recent years much study has gone into understanding the
precise molecular mechanism regulating M1/M2 development
and polarization. Several studies have implicated key transcription
factors and regulatory proteins in this process, including members
of the interferon regulatory factor (IRF) family, signal transducer
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anti-inflammatory protein that functions to convert PIP3 to
PI(3,4)P2 in order to turn off PI3K-dependent signalling and
negatively regulate NF-kB and IRF3 activity via regulating
complex formation and the localisation of key signalling proteins
such as TBK1 [17–19]. Interestingly, induction of the microRNA
miR-155 has been associated with an enhanced M1 phenotype as
a result of SHIP1 down regulation [20]. Recently the inhibitory
p50 subunit of NF-kB has also been shown to contribute to the
process of tolerance and thus M2 macrophage induction by
negatively regulating M1 macrophage polarization and IFN-b
induction [9]. Furthermore, the suppressors of cytokine signaling
(SOCS) proteins also contribute to macrophage polarization, with
SOCS3 regulating M1 development while SOCS2 promotes an
M2 phenotype [21].
Stimulation of macrophages via Toll Like receptors (TLRs) such
as TLR4 or TLR9 has been shown to be a critical signal in driving
macrophage polarization via activation of NF-kB or the IRF
family members. The Tec tyrosine kinase, Bruton’s tyrosine kinase
(Btk), is critical for LPS-induced proinflammatory cytokine
production and IFN-c-induced natural killer cell activation [22–
26]. Btk interacts with TLR2, 3, 4 and 7 and in doing so mediates
their phosphorylation and the transduction of downstream signals.
At a molecular level Btk regulates NF-kB activation by regulating
p65 phosphorylation downstream of multiple TLRs including
TLR4, 7 and 9 [23–26]. In addition Btk regulates IRF3 activation
downstream of TLR3 and hence IFN-b production in response to
viral recognition [27]. Interestingly, IRF3 and IRF5 have been
implicated in regulating M1 polarization and associated gene
induction [28,29]. Thus as a critical regulator of transcription
factors such as NF-kB and the IRFs, the possibility exists that Btk
may regulate macrophage polarization downstream of classical
M1and M2 polarizing stimuli.
To fully address this possibility we examined polarisation of
macrophages derived from Btk2/2 mice, which allowed us to
directly determine the exact contribution of Btk to this dynamic
process. This study shows that Btk plays an important role in
regulating LPS-driven M1 polarisation, with impaired recruitment
of M1 macrophages and preferential polarisation towards an M2
phenotype observed in the absence of Btk following stimulation
with IL-4 and IL-13 or in vivo challenge with Schistosoma mansoni
eggs, a classic model of allergic inflammation. This bias towards an
M2 phenotype could not be recovered by treatment with an M1
polarizing cocktail, as this too was shown to promote M2associated gene induction. At a molecular level, enhanced STAT6
and reduced NF-kB p65, Akt and STAT1 phosphorylation as well
as altered SHIP1 induction was shown to contribute to this skew.
These studies demonstrate a critical role for Btk in macrophage
polarisation with Btk acting as a negative regulator of M2
macrophage induction.

Mice
Btk deficient (Btk2/2) mice on a C57BL/6 background were a
kind gift from Dr Rudi Hendriks [30]. Mice were housed at the
Biomedical Research Facility at the Royal College of Surgeons in
Ireland under specific pathogen-free conditions. Animals were
housed with 12 hour day-night cycle with lights on at 7:30 pm in a
temperature (2261uC) and humidity (5565%) controlled room.
The animals’ health status was monitored prior to and throughout
the experiments and all mice were free of all viral, bacterial, and
parasitic pathogens. Prior to commencement of experiments the
animals were separated and housed in relevant treatment groups
in individually ventilated cages. Each treatment group consisted of
3–4 animals and experiments were performed in triplicate. Prior to
and during the experimental period all mice were allowed free
access to sterile water and nutrition. All cages contained bedding
and were enriched with mouse houses. All efforts were made to
minimise suffering.

Intraperitoneal (i.p) LPS Injection
Age-matched (6 to 10 weeks) wild type (WT) (n = 4) C57BL/6
mice (Harlan Laboratories) and Btk2/2 mice (n = 4) were
administered an intraperitoneal injection (i.p.) of 1 mg/kg LPS
dissolved in sterile saline solution. Control mice were given an i.p.
injection of the equivalent volume of saline. Following 24 hour
LPS treatment mice were culled by CO2 asphyxiation.

Isolation of Peritoneal Macrophages
Peritoneal cells were harvested by peritoneal lavage with of
10 ml sterile ice cold PBS. Peritoneal cells were allowed to adhere
to plates for 4 hours. Non-adherent cells were subsequently
removed by washing with RPMI, and the adherent macrophages
were refed with RPMI containing 20% calf serum and gentamicin.
Purity of adherent cells (.95%) was determined by flow cytometry
following staining with using F4/80 and CD11b (BD Biosciences).
Macrophages were used for experiments immediately following
isolation. For some experiments macrophages were treated ex vivo
with an M1 (100 U/ml IFN-c plus 100 ng/ml LPS) or an M2
(10 ng/ml IL-4 plus 10 ng/ml IL-13) polarizing cocktail for the
indicated time points.

Flow Cytometric Analysis
Peritoneal macrophages were collected from WT or Btk2/2
mice following i.p. LPS injection. Cells were stained for F4/80,
CD11b, CD86, and IA/IE (MHCII), using specific antibodies (BD
Biosciences) and analysed by flow cytometry using a FACSCantoII
flow cytometer (BD Biosciences).

Real-time PCR
Total RNA was extracted using an RNeasy kit (Qiagen) and
reverse transcribed to cDNA using Omniscript reverse transcriptase (Qiagen) according to manufacturer’s recommendations.
Quantitative real-time PCR was performed using SYBR Green
Taq ReadyMixTM (Sigma) and the data was normalised to a bactin reference. Real-time PCR data was analyzed using the
22DDCt method [31].

Materials and Methods
Ethics Statement
All mouse work was carried out in strict accordance with the
requirements of Royal College of Surgeons in Ireland Ethics
Committee with ethics approval number: REC582. Animals were
culled using CO2 asphyxiation and the appropriate organs and
cells harvested.

Helminth Egg Injections
Eggs from S. mansoni–infected mice were obtained as described
previously [32]. WT mice (n = 4) or Btk2/2 mice (n = 4) were given
an intravenous (i.v)injection of either 5,000 S. mansoni eggs or PBS.
Mice were killed on day 14 and lungs were removed. Lungs lobes
were snap-frozen or homogenised for analysis of macrophages by
flow cytometry or qPCR, as described previously [33].

Reagents
LPS was purchased from Cayla Invivogen (Escherichia coli
0111:B4). Recombinant murine IFN-c, IL-13 and IL-4 were
purchased from Immunotools.
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mice (Figure 1 D). In addition, analysis of MHC Class II
expression within M1 and M2 gates as defined in Figure 1A
revealed that the majority of expression for this antigen was within
the F4/80intCD11bhi (M1) gated region, with WT peritoneal
macrophages displaying enhanced levels of MHC class II when
compared to Btk-deficient peritoneal macrophages (Figure 1 E).
Furthermore reduced expression of Ly6C was observed on
infiltrating myeloid cells following LPS treatment in Btk2/2 mice
compared to WT mice (Figure 1 F). This data suggests that in the
absence of Btk M2-like macrophages are preferentially recruited
following exposure to LPS.
Polarized macrophage subsets can be further distinguished
according to the array of cytokines and chemokines they
differentially secrete [39,40]. We investigated gene induction
profiles of M1- and M2- associated genes in WT and Btk2/2
peritoneal macrophages following ex vivo LPS treatment (Figure 1
G–H). As expected, LPS-treated WT peritoneal macrophages
displayed significantly enhanced expression of the characteristic
M1-associated genes Tnfa, Il12p40 and Cxcl10 when compared to
Btk2/2 cells (Figure 1G). In contrast, LPS-treated Btk2/2
macrophages had significantly reduced expression of M1-associated genes but enhanced expression of the M2-associated
chemokines Ccl2, Ccl17 and Ccl22 in comparison to WT
macrophages (Figure 1H). Thus not only are Btk2/2 macrophages
defective in their ability to induce proinflammatory cytokines in
response to LPS [23–26], they appear to preferentially polarize
towards anti-inflammatory M2 macrophages in response to this
normally pro-inflammatory stimulus.

In vivo Macrophage Activation
WT mice (n = 4) or Btk2/2 mice (n = 4) were injected i.p. with
approximately 800 ng Chitin (Sigma) with to induce M2 cells in
the peritoneum as previously described [34]. Peritoneal cells were
collected by lavage after 48 hours and gene induction was
determined by qPCR.

Western Blot Analysis
WT and Btk2/2 BMDMs were treated ex vivo with an M1 or
M2 polarizing cocktail as indicated. Expression of STAT1(Santa
Cruz Biotechnology #sc-592), STAT6 (Santa Cruz Biotechnology
#sc-621), pY-STAT1 (Cell Signaling #9171), pY-STAT6 (Imgenex #IMG408A), Akt (Cell Signaling #9271), pS-Akt (Cell
Signaling #9272), NF-kB p65 (Santa Cruz Biotechnology #sc372), pS-NF-kB p65 (Cell Signaling #3036S), iNOS (Transduction Laboratories #N39120) and SHIP-1 (Santa Cruz Biotechnology #sc8425), was determined by Western blot as described
previously [23].

Statistical Analysis
Student’s unpaired t test was performed using GraphPad Prism
6.0. Results are presented as mean 6 STD. Data were deemed to
be significantly different at P values less than 0.05.

Results
Btk is Required for LPS-elicited Macrophage Polarization
in vivo
Given the role of Btk as a central regulator of TLR4-driven proinflammatory cytokine production [22,23,25,26], we sought to
determine whether Btk was involved in regulating in vivo M1/M2
differentiation downstream of TLR4. To date several surface
antigens have been employed in order to discriminate between
polarized macrophage populations. Initial studies have suggested
that size and relative expression of F4/80 and CD11b can
distinguish subtypes which are loosely defined as F4/80intCD11bhi
M1-like macrophages and F4/80hiCD11bhi M2-like macrophages
[35]. However, while this approach has utility, the authors noted
that this technique did not fully address the heterogeneity of the
population. It is now therefore accepted that in addition to F4/80
and CD11b the relative expression of antigen presentation
molecules, co-stimulatory molecules and Ly6C can be used to
more fully discern polarized macrophages, with M1 macrophages
demonstrating increased expression of these antigens relative to
M2 macrophages [36–38]. Taking these approaches into account,
LPS was injected i.p. into WT and Btk 2/2 mice and 24 hours
later peritoneal macrophages were profiled by flow cytometry for
F4/80 and CD11b (Figure 1A), following which analysis of the
relative proportion of F4/80intCD11bhi M1-like macrophages and
F4/80hiCD11bhi M2-like macrophages was performed (Figure 1B
and 1C, respectively). Gating on F4/80intCD11bhi we assessed the
effect of LPS on recruitment of M1-like macrophages to the
peritoneum and found that in the absence of Btk significantly
reduced levels of F4/80intCD11bhi cells (8.5% v 4.8%; p#0.05)
were observed compared to WT mice (Figure 1 B). Additionally
we assessed recruitment of M2-like macrophages by gating on F4/
80hiCD11bhi cells and determined that significantly enhanced
levels of these cells (41.5% v 20.9%; p#0.05) were recruited to the
peritoneum in the Btk-deficient mice compared to similarly treated
WT mice (Figure 1 C). Consistent with suggestions that that these
F4/80hiCD11bhi cells represent an influx of M2-like macrophages
Btk-deficient peritoneal macrophages displayed reduced levels of
the co-stimulatory molecule CD86 (33% v 62%) and reduced
expression of MHC class II (39% v 73%) when compared to WT
PLOS ONE | www.plosone.org

Dominant M2 Phenotype in Macrophages Lacking Btk
Given that polarized macrophage states can be modulated or
reversed [41], we next asked whether Btk2/2 macrophages would
polarize normally in response to either M1 or M2 polarizing
stimuli. Peritoneal macrophages isolated from WT and Btk2/2
mice were treated ex vivo with either an M1 (LPS plus IFN-c) or an
M2 (IL-4 plus IL-13) polarizing cocktail and gene induction was
determined by real time PCR. As expected, treatment with the M1
polarizing cocktail resulted in robust induction of Tnfa, Il12 and
Cxcl10 in WT macrophages (Figure 2 A). However, similarly
treated Btk2/2 macrophages demonstrated impaired induction of
M1-associated genes, instead showing a marked propensity to
express M2-associated genes (Figure 2 B). Treatment with the M2
polarizing cocktail resulted in expression of M2-associated genes in
WT and Btk2/2 macrophages; however Btk2/2 macrophages
exhibited significantly enhanced induction of M2-associated genes
when compared to WT macrophages (Figure 2 D; p#0.05). Thus
our results strongly indicate that Btk2/2 macrophages preferentially polarize to an M2 phenotype and that these cells are
incapable of switching to an M1 phenotype following exposure to
IFN-c and LPS. Indeed the M2 skew is exacerbated by exposure
to M2 polarizing stimuli in the Btk2/2 macrophages compared to
WT, indicating that pathways governing M2 polarization are
constitutively primed in Btk2/2 macrophages.

Altered Phosphorylation of Key Signalling Intermediaries
in the Absence of Btk
We next sought to investigate the mechanism by which Btk
contributes to macrophage polarisation. Investigating the effects of
LPS or IFN-c on STAT1 activation we observed that tyrosine
phosphorylation of STAT1 was impaired in the absence of Btk
following culture of BMDMs with either LPS or IFN-c alone
(Figure 3 A). Additionally the combination of LPS and IFN-c also
induced less STAT1 phosphorylation in Btk2/2 BMDMs
compared to WT BMDMs (Figure 3 B). Consistent with increased
3
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Figure 1. Impaired TLR4-mediated induction of peritoneal M1 cells in Btk2/2 mice in vivo. (A–E) Peritoneal macrophages were harvested
from WT or Btk2/2 mice following i.p. LPS injection. (A) Representative plots demonstrate the gating strategies for macrophage discrimination where
total peritoneal macrophages were defined following co-staining with CD11b APC-Cy7 and F4/80 PE-Cy7. (B–C) Macrophage subsets were further
distinguished as F4/80intCD11bhi M1-like macrophages and F4/80hiCD11bhi M2-like macrophages (M1 and M2 gates, respectively). The relative
percentage of M1 (B) and M2 (C) macrophages within the total macrophage gate were determined for WT or Btk2/2 mice following i.p. LPS injection.
(D) Expression of CD86 and MHC Class II was determined by flow cytometry. (E) MHC Class II expression was examined within the defined M1 and M2
gates following co-staining with F4/80 and CD11b. (F) Ly6C was determined by flow cytometry. In all cases data is presented as percent increased
expression above background as determined by staining with the relevant isotype control (indicated by markers in panel (D). (G–H) Peritoneal
macrophages harvested from WT or Btk2/2 mice were treated ex vivo with LPS (100 ng/ml) for the indicated time course and the induction of M1- (G)
and M2- (H) associated genes was determined by real time PCR (qPCR). Peritoneal macrophages were pooled after isolation, with each treatment
group consisting of 3–4 animals, and all experiments were performed in triplicate. Student’s paired t test was performed comparing gene induction in
Btk2/2 peritoneal macrophages to WT cells at the indicated time points. Results shown are mean6SD from three independent experiments.
* = p#0.05.
doi:10.1371/journal.pone.0085834.g001
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Figure 2. Btk2/2 macrophages have impaired ability to expand in vitro into M1 cells. (A–D) Peritoneal macrophages were extracted from
WT and Btk2/2 mice and treated ex vivo with an M1 (LPS plus IFN-y) or an M2 (IL-4 plus IL-13) polarizing cocktail for 24 hr and induction of M1 (A–B)
and M2- associated (C–D) genes determined by qPCR. In all cases peritoneal macrophages were pooled after isolation, with each treatment group
consisting of 3–4 animals, and all experiments were performed in triplicate. Student’s paired t test was performed comparing gene induction in Btk2/2
peritoneal macrophages to WT cells following treatment with polarizing cocktails as indicated. Results shown are mean6SD from three independent
experiments. * = p#0.05.
doi:10.1371/journal.pone.0085834.g002

M1/M2 differentiation, we observed significantly less phosphorylation of p65 in Btk2/2 BMDMs compared to WT BMDMs
following LPS and IFN-c treatment, whereas M2 polarizing
conditions failed to promote p65 phosphorylation either in WT or
Btk2/2 BMDMs (Figure 3 C). Similarly phospho-Akt levels were
also reduced under the same conditions in Btk2/2 BMDMs, and
again M2-polarizing signals failed to induce Akt activation in
either WT or Btk2/2 cells. In addition under the same conditions,
we observed potent induction of the classical pro-inflammatory
M1-associated marker iNOS in WT BMDMs when compared to
Btk2/2 BMDMs (Figure 3 D), with M2 polarizing signals having

generation of M2 macrophages in the absence of Btk, we observed
enhanced phosphorylation of STAT6 in response to IL-4 and IL13 in the Btk2/2 BMDMs compared to WT BMDMS (Figure 3 B,
lower panel).
It is well established that in addition to STAT activation M1
and M2 polarizing signals modulate the expression of inflammatory genes via differential activation of transcription factors,
including NF-kB, as a result of activation of key pathways
including PI3K/Akt [42]. Not surprisingly given the previously
identified role for Btk in regulating p65 phosphorylation and
hence NF-kB activation, and the role NF-kB plays in regulating
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Figure 3. Altered phosphorylation of key signalling intermediaries in the absence of Btk. (A) WT and Btk2/2 BMDMs were treated ex vivo
with LPS (100 ng/ml) or IFN-c (100 U/ml) for 3 hours or 15 minutes, respectively, lysates were prepared and phosphorylated Y701-STAT1 levels
determined by Western blot. WT and Btk2/2 BMDMs were treated ex vivo with an M1 or M2 polarizing cocktail over the indicated time course, lysates
were prepared and tyrosine phosphorylated STAT1 and STAT6 (B), serine phosphorylated AKT (upper panel) and NF-kB p65 (lower panel) (C) iNOS
and SHIP-1 (D) levels were determined by Western blot. Results in each case are representative of three independent experiments. Densitometric
analysis was performed and graphs represent phosphorylated protein levels relative to unphosphorylated proteins (B-C) or changes in total protein
levels relative to b-actin (D) for WT and Btk2/2 BMDMs. Student’s paired t test was performed comparing relative expression of phosphorylated or
total proteins in Btk2/2 BMDMs to WT BMDMs following treatment with polarizing cocktails as indicated. Results shown are mean6SD from three
independent experiments. * = p#0.05.
doi:10.1371/journal.pone.0085834.g003
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To date there has been no direct evidence supporting a role for
Btk in macrophage polarization and reports of Btks contribution to
inflammation have been controversial. Several studies have
suggested that Btk functions as a negative regulator of inflammation [45–47] while there is gathering evidence to suggest that Btk
may be important in driving the inflammatory process. Studies
examining APCs derived from XLA patients, who have a natural
mutation in Btk, have shown that they have defects in both
phagocytosis and inflammatory cytokine production following
TLR stimulation [25,26,48]. Recently the potential that Btk plays
a direct role in positively regulating antigen presentation and
maturation of APCs was described by Lui et al. These studies
found impaired TLR-driven activation of APCs due to an inability
to form a MHC class II and CD40 complex in the absence of Btk
[49]. At a molecular levels Btk has been shown to stabilise TNF-a
mRNA via a p38- dependent pathway in X-linked immunodeficiency (Xid) mice and in XLA patients as well as being critically
involved in NF-kB activation and specifically p65 phosphorylation
downstream of multiple TLRs including TLR4, TLR7 and TLR9
[23–26]. More recently studies by our group have suggested that
increased IL-10 production together with a significant reduction in
IFN-c production in the absence of Btk may result in an altered
Th1/Th2 balance [22], potentially implicating Btk in macrophage
polarization. In the current study we observed impaired activation
of NF-kB p65 in the absence of Btk following TLR4 and IFN-c
treatment, further supporting a positive role for Btk in M1
macrophage polarisation. Interestingly, M2 macrophages have
been shown to inhibit the expression several M1 associated
chemokines including CXCL10 by modulating the activity of both
NF-kB and STAT1 [50,51]. We observed impaired phosphorylation of Akt, a key MyD88-dependent signalling intermediary and
inducer of M1-associated cytokines [52,53] in the absence of Btk.
Studies in B cells have shown that Btk and Akt directly interact
and that in the absence of Btk, Akt activation is prevented [53]. A
recent study has implicated Akt as a negative regulator of Btk,
phosphorylating it in order to promote 14-3-3f binding, a novel
negative regulator of Btk signalling [54]. Thus the ability of Btk
and Akt to cross-regulate each other and the involvement of Akt in
regulating macrophage polarization, indicates that the inability of
Btk2/2 macrophages to phosphorylate Akt in response to M1
polarizing stimuli has an important contribution to the M2 skew
observed in these cells.
Whilst a direct link between Btk and STAT1 in regulating
macrophage activity has not been previously demonstrated,
overexpression studies and studies in B cells have demonstrated
that Btk and other Tec family kinases can interact with STAT
family members and promote or inhibit their activation. Btk has
been shown to interact directly with JAK1 and this association
results in Btk phosphorylation [55]. More recently the absence of
Btk was shown to result in reduced polyI:C-mediated activation of
STAT1 [27]. Relevant to our findings, Btk has been shown to
prevent STAT3 activation in B cells thus promoting apoptosis
[56]. Overall our study indicates that Btk is required for optimal
STAT1 activation and that in the absence of Btk, enhanced
STAT6 phosphorylation is observed, in keeping with the
inhibitory role for Btk regarding STAT3 activation reported by
Uckun et al [56]. Given that Btk has been implicated as key
positive regulator of TLR4-mediated cytokine production and that
STAT1 activation is required for optimal LPS induced activation
of macrophages [57], this study demonstrates an important link
between Btk activation, subsequent transcription factor phosphorylation and macrophage polarization.
Interestingly whilst exposure of Btk-deficient macrophages to
M1 polarizing stimuli did not result in increased STAT6

no effect. These results indicate that Btk mediates M1 gene
induction via promoting Akt and p65 activation. Regarding what
might drive Btk2/2 macrophages to become skewed towards an
M2 phenotype even in the presence of M1 polarizing signals,
SHIP1, as a key anti-inflammatory protein that negatively
regulates PI3K-dependent signalling and subsequently activation
of NF-kB and IRF3 thus negatively regulating M1 macrophage
polarisation, is a potential target [17–19]. In keeping with the
importance of SHIP1 in promoting M2 polarization, treatment
with IL-4 and IL-13 resulted in expression of SHIP1 in both WT
and Btk2/2 BMDMs, however expression levels were enhanced in
Btk2/2 macrophages compared to WT macrophages, suggesting
inappropriate regulation of SHIP-1 expression and potentially
activity in Btk2/2 BMDMs contributes to the M2 skew observed
(Figure 3 D, lower panel). Thus in the absence of Btk diminished
activation of key signaling intermediaries and transcription factors
and enhanced expression of the M2-promoting proteins including
STAT6 and SHIP1 accounts for the inability of macrophages to
effectively polarize towards an M1 phenotype.

Absence of Btk Exacerbates M2 Recruitment and
Induction Following Induction of Allergic Inflammation
To date our data suggests that loss of Btk results in a
predominant M2 phenotype which may potentially aggravate
M2-mediated disease such as allergic inflammation. Both Schistosoma mansoni eggs and chitin drive allergic inflammation via
promoting M2 induction and a Th2-mediated response [43,44].
We hypothesised that M2 induction would be exacerbated in the
absence of Btk. WT and Btk2/2 mice were injected i.v. with 5,000
S. mansoni eggs and 14 d later M2 macrophages were analysed in
lungs by flow cytometry, with induction of M1 or M2 associated
genes determined by qPCR. In keeping with our previous findings,
we observed a significant (p#0.05) increase in recruitment of M2
macrophages to the lungs of Btk2/2 mice compared to WT mice
(Figure 4 A), accompanied by a preferential induction of M2associated genes, Arginase 1 and Relm-a, in Btk2/2 mice
compared to WT mice (Figure 4 B and C).
To further address the role of Btk in in vivo generation of M1
versus M2 cells, WT and Btk2/2 mice were injected i.p. with
chitin following which peritoneal cells were collected by lavage
and M1/M2 gene induction determined by qPCR. Similar to S.
mansoni challenge, chitin treatment of Btk2/2 mice resulted in
enhanced induction of the M2-associated genes Arginase 1 and
Relm-a, in peritoneal exudate cells compared to controls (Figure 4
D). Similar to the enhanced basal levels of M2-associated genes in
the peritoneum following in vivo LPS treatment (Figure 1 G) we
also observed enhanced basal levels of M2-associated genes in vivo
(Figure 4 B–D). Collectively, using two separate M2 inducing
in vivo mouse models, in lungs or peritoneum, there is marked
polarization to M2 cells in the absence of Btk.

Discussion
This study demonstrates a novel role for Btk in determining
macrophage lineage commitment, with preferential M2 macrophage induction observed in the absence of Btk as a result of
altered activation of key signaling pathways and transcription
factors such as NF-kB p65, Akt and proteins known to regulate
macrophage polarization including SHIP1 and members of the
STAT family. Furthermore we show that Btk is essentially
required downstream of TLR4 and IFN-c for optimal p65dependent and STAT1-dependent M1 macrophage polarization
(Figure 5).
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Figure 4. Increased in vivo M2 macrophage generation in the absence of Btk. (A–C) WT and Btk2/2 mice were injected i.v. with 5,000 live
S.mansoni eggs. (A) The percentage of pulmonary M2 macrophages was evaluated by flow cytometry using F4/80 and CD11b co-staining. (B–C)
Induction of M2-associated genes was determined by qPCR. (D) WT and Btk2/2 mice were injected i.p. with approximately 800 ng Chitin. Peritoneal
cells were collected by lavage after 48 hours and gene induction of M2-associated genes was determined by qPCR. In all cases peritoneal
macrophages were pooled after isolation, treatment groups consisted of 3–4 animals, and experiments were performed in triplicate. Student’s paired
t test was performed comparing gene induction following in vivo exposure to S.mansoni eggs or Chitin as indicated in WT and Btk2/2 peritoneal
macrophages. Results shown are mean6SD from three independent experiments. * = p#0.05.
doi:10.1371/journal.pone.0085834.g004

macrophages play an important role in directing disease outcome
[2,4]. Indeed the enhanced production of M2-associated chemokines by alveolar macrophages is thought to contribute to small
airway and peripheral lung inflammation observed in asthma
patients [63]. Our data in two models of allergic disease
demonstrate that a lack of Btk exacerbates M2 polarization,
indicating the critical role of this protein in ensuring a balanced
response and strongly suggests that lack of a proper M1/M2
balance in the lung in the absence of Btk may exacerbate allergic
inflammation. Indeed a study of allergic airway inflammation in
mice reports increased IgE responses an exaggerated airway
inflammation in the absence of Btk [64]. Clinically, most likely due
to absent circulating immunoglobulin and a role for Btk in mast
cell degranulation, reports of allergy in XLA patients are rare
[65,66]. Despite the rarity of allergic reactions, pulmonary
complications such as decreased lung function and increased
thickening have been observed in XLA patients [67]. Given the
known role of macrophages in driving airway disease, it is
tempting to propose that an M1/M2 imbalance may be driving
this response.
Btk inhibitors are currently in trial for a number of conditions
including B cell malignancies and inflammatory autoimmune
conditions [68,69]. Whilst undoubtedly Btk inhibitors contribute
to reduced production of pro-inflammatory cytokines by macrophages, Btk inhibition also affects apoptotic cell uptake, in addition
to its role in regulating macrophage polarization as demonstrated

phosphorylation or SHIP1 induction, we did however observe
significantly impaired activation of key M1 promoting signalling
molecules, such as NF-kB p65, STAT1 and AKT, as previously
published [6–9]. Together our data suggests that not only is Btk
critical for the induction of signals driving M1 polarization but that
it also functions as a negative regulator of M2-polarizing signalling
pathways, as evidenced by the hyper-phosphorylation of STAT6
and increased induction of SHIP1 we observed following IL-4 and
IL-13 treatment in the absence of Btk. The possibility therefore
exists that much like SHIP1 [58–60] and Akt [61,62], Btk may
have a dual function in mediating macrophage polarization. This
role is supported by studies demonstrating that Btk phosphorylates
the key TLR4 adaptor Mal, resulting in SOCS1-mediated
ubiquitination and degradation of Mal and hence negative
regulation of TLR4-dependent pathways [7]. Additionally unpublished observations in our group demonstrate that SHIP1 and Btk
interact and that this interaction regulates the phosphorylation and
presumably the activity of SHIP1 in an as yet undetermined
manner. Thus the lack of Btk contributes not only to the
expression of SHIP1 but may also play a role in regulating its
activity.
Thus our data suggests that loss of Btk results in a predominant
M2 phenotype which may potentially exacerbate Th2 mediated
disease such as allergic asthma. Asthma is traditionally thought of
as a disease mediated by an imbalance between Th1/Th2/Th17
cells, however it is becoming more apparent that alveolar
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Figure 5. Proposed transcriptional regulation of macrophage polarization in the absence of Btk. (A) This study has demonstrated that in
response to LPS and IFN-c Btk contributes to M1 polarizing of myeloid cells via promoting the phosphorylation of Akt and subsequently the p65
subunit of NFkB, in addition to enhancing to phosphorylation of STAT1. (B) In the absence of Btk exposure of myeloid cells to LPS and IFN-c results in
the preferential induction of M2 associated genes and preferentially recruitment of M2 cells in vivo. Previous studies in Btk2/2 mice have observed
increased levels IL-10 systemically following LPS treatment. IL-10 is known to activate STAT3 and there is some evidence to suggest that STAT3 may
also play a role in promoting M2 macrophage polarization. Thus in the absence of Btk, in response to M1 polarizing stimuli increased IL-10 production
together with reduced phosphorylation of key signaling intermediaries, combined with activation of p50 the inhibitory subunit of NF-kB could
potentially account for the observed preferential skew towards an M2 phenotype. Additionally this study has shown that in response to IL-4 and IL-13
Btk2/2 cells demonstrate an increased capacity to polarize towards an M2 phenotype as a result of enhanced STAT6 phosphorylation and increased
SHIP1 expression.
doi:10.1371/journal.pone.0085834.g005

here [70]. Given the emerging role for macrophages in allergy,
asthma, cancer and certain autoimmune conditions such as
systemic lupus erythematosus, our findings suggest that manipulation of Btk activity may have unwanted effects in certain disease
settings and indicates the need for more extensive analysis of the
role of Btk in macrophages in inflammatory disease.
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